Vision

MetaImmuneTech empowers a new era of immune health by making immune diagnostics faster, simpler, and more accessible through digital in-line holography technology—transforming the way we monitor and manage immunity worldwide.
Mission
To advance immune health by delivering accessible and accurate
cell-based diagnostics powered by digital in-line holography.
cell-based diagnostics powered by digital in-line holography.

History
2023~
2020~2022
2025
2024
2023
02
Certified with ISO13485 for medical device quality management system04
Selected for the 2025 Agri-Food Venture Fostering Project (Ministry of Agriculture)04
Selected for the 2025 Export Voucher Support Project (Ministry of SMEs and Startups)04
Selected for the 2025 National Research Equipment Technology Competition (Ministry of Science and ICT)04
Selected for the Tech Incubator Program for Startups (TIPS) Scale-up R&D project06
Cellytics System received Grade 1 certification for in-vitro diagnostic devices07
Cellytics NK – Winner of MEDITEK Innovation Award 2024 Best in Class12
Minister of Science and ICT Award in Basic Science Division, Science and Technology Awards03
Establishment of Corporate Research Institute (KU Sejong campus)05
Science Belt R&D Grant awarded (MSIT, 1 billion KRW)06
ITRC program awarded (MSIT)08
CellyticsTM NK prototype completed (System + Reagent kit)09
Clinical research of Cellytics NK in Hematologic cancer started (KUH Ansan)Clinical research of Cellytics NK in Liver disease started (KUH Guro)
Clinical research in NSCLC patient monitoring with NK cell therpay (Vaxcell Bio, CNUHH)
10
Cellytics NK – CES 2024 Innovation Award Honoree (Digital Health)12
Cellytics NK Sep-kit received Grade 1 certification for in-vitro diagnostic devices2022
2021
2020
03
Acquisition of patents related to LSIT-based NK cell activity assay from KU05
TIPS R&D grant awarded (MSS, 500 million KRW)09
Clinical research of Cellytics NK started in collaboration with KUH Anam (Normal vs Cancer)11
Commercialization Support Program granted (MSS)12
Investment from SRI OB Private fund (70 million KRW)02
Selected as Best Company in the pre-start-up package programAcquisition of patents related to obesity treatment from Korea University
05
First stage Start-up package program awarded (KISED)12
Investment from Korea University Holdings (Seed, 100 million KRW)11
Pre-start-up package program awarded (KISED)MetaImmuneTech Inc. established (Capital 92.5 million KRW)